reviewTop 1% cited
The odyssey of marine pharmaceuticals: a current pipeline perspective
Trends in Pharmacological Sciences · 2010 · Vol. 31(6) · pp. 255–265
Alejandro M. S. Mayer✉(Midwestern University)Keith B. Glaser(Abbott Fund)Carmen Cuevas(PharmaMar (Spain))Robert S. Jacobs(University of California, Santa Barbara)William R. Kem(Florida College)R. Daniel Little(University of California, Santa Barbara)J. Michael McIntosh(University of Utah)David Newman(National Cancer Institute)Barbara C. M. PottsDale E. Shuster(Eisai (United States))
Computational Drug Discovery MethodsBiotechnology and Related FieldsPipeline (software)Food and drug administrationMedicineClinical trialDrugPharmacologyEngineeringInternal medicine
MeSH terms
AnimalsBiological ProductsClinical Trials as TopicDrug Evaluation, PreclinicalHumansMarine BiologyUnited StatesUnited States Food and Drug AdministrationDrugs, InvestigationalDrug Discovery
Funding
- Midwestern University
Citations
652
FWCI
50.68
field-weighted impact
References
92
Percentile
100%
vs. same field & year
Citations per year
Cited by
Approved Antiviral Drugs over the Past 50 Years
Clinical Microbiology Reviews · 2016 · 1,404 citations
How were new medicines discovered?
Nature Reviews Drug Discovery · 2011 · 1,768 citations
References
Discovery and development of the anticancer agent salinosporamide A (NPI-0052)
Bioorganic & Medicinal Chemistry · 2008 · 284 citations
Marine pharmacology in 2005–6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action
Biochimica et Biophysica Acta (BBA) - General Subjects · 2009 · 452 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.